Women with DePuy hip implants may require revision surgery at a higher rate then men according to data from the National Joint Registry of England and Wales.
In August 2010, DePuy Orthopedics recalled the ASR Hip Resurfaacing System and ASR XL Acetabular System total hip replacement after the devices were linked to higher failure rates than other hip replacement products.
The University of Adelaide in Australia found that the a patient’s hip size is one factor in higher failure rates in some patients. Patients that were implanted with ASR femoral head sizes below 50mm in diameter were at a greater risk for a second surgery. This affects mostly smaller and female patients.
Since DePuy first marketed the ASR hip implant systems, there has been a 12-13% failure rate of the hip within five years of the initial surgery. Approximately 93,000 people have received the implants.
Joint replacement agencies in both Australia and in the United Kingdom discovered that patients were having higher than expected complications including loosening of the implant with the body, bone fractures near the implant, dislocation and a condition called metallosis which is a condition when there is metal-on-metal rubbing of the implant. The United States does not have a Joint Registry.
The Farber Law Group has more than 30 years experience representing clients with their product liability cases caused by injuries from defective products including medical devices.
To discuss your case or concerns with an experienced Bellevue DePuy hip recall attorney, contact us now at (800) 244-9087, or by e-mail at firstname.lastname@example.org.
Recalled DePuy Hip Devices May Have Higher Failure Rate in Women
DrugWatch.com Posted: December 28, 2010
Nearly half of DePuy ASR hip implant patients in Ireland may need 2nd surgery
Contact The Farber Law Group at 1-800-244-9087 or email@example.com to schedule a free and confidential case evaluation. We have offices in Seattle and Bellevue to assist you.